JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 19 March 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02176-07v1
82/11/5398    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emu, B.
Right arrow Articles by Deeks, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emu, B.
Right arrow Articles by Deeks, S. G.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.02176-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

HLA Class I-Restricted T Cell Responses May Contribute to the Control of HIV Infection, but Such Responses are Not Always Necessary for Long-term Virus Control

Brinda Emu*, Elizabeth Sinclair, Hiroyu Hatano, April Ferre, Barbara Shacklett, Jeffrey N. Martin, J. M. McCune, and Steven G. Deeks

Positive Health Program, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA; Division of Experimental Medicine, University of California, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA; Department of Microbiology and Immunology, University of California, Davis, CA

* To whom correspondence should be addressed. Email: brinda.emu{at}ucsf.edu.


   Abstract

A rare subset of HIV-infected individuals maintains undetectable HIV RNA levels without therapy ("elite controllers"). To clarify the role of T cell responses in mediating virus control, we compared HLA Class I polymorphisms and HIV-specific T cell responses among a large cohort of elite controllers (HIV-RNA <75 copies/mL), "viremic" controllers (low-level viremia without therapy), "non-controllers" (high level viremia), and "antiretroviral therapy suppressed" individuals (undetectable HIV-RNA levels on antiretroviral therapy). The proportion of CD4+ and CD8+ T cells that produce interferon-{gamma} and interleukin-2 in response to Gag and Pol peptides was highest in the elite and viremic controllers (p<0.0001). Forty percent of elite controllers were HLA-B*57 compared to 23% of viremic controllers and 9% of non-controllers (p<0.001). Other HLA Class I alleles more common in elite controllers included HLA-B*13, B*58, and B*81 (p<0.05 for each). Within elite and viremic controller groups, those with protective class I alleles had higher frequencies of Gag-specific CD8+ T cells compared to those without these alleles (p=0.01). Non-controllers, with or without protective alleles, had low-level CD8+ responses. Thus, certain HLA Class I alleles are enriched in HIV controllers and are associated with strong Gag-specific CD8+IFN{gamma}+IL-2+ T cells. However, the absence of evidence of T cell-mediated control in many controllers suggests the presence of alternative mechanisms for viral control in these individuals. Defining mechanisms for virus control in "non-T cell controllers" might lead to insights into preventing HIV transmission, or preventing virus replication.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.